A randomized double-blind placebo-controlled trial to investigate the effectiveness and safety of a novel green-lipped mussel extract - BioLex® - for managing pain in moderate to severe osteoarthritis of the hip and knee

被引:28
|
作者
Stebbings, Simon [1 ]
Gray, Andrew [2 ]
Schneiders, Anthony G. [3 ]
Sansom, Andrew [4 ]
机构
[1] Univ Otago, Dunedin Sch Med, Dept Med, Dunedin, New Zealand
[2] Univ Otago, Dept Prevent & Social Med, Dunedin, New Zealand
[3] Cent Queensland Univ, Sch Human Hlth & Social Sci, Branyan, Australia
[4] Seperex Nutr, Ctr Innovat, Dunedin, New Zealand
关键词
Green lipped mussel extract; Randomized controlled trial; Osteoarthritis; PERNA-CANALICULUS; STANDING-COMMITTEE; CLINICAL-TRIALS; TASK-FORCE; RECOMMENDATIONS; ARTHRITIS; CRITERIA; CLASSIFICATION; COMPLEMENTARY; VALIDATION;
D O I
10.1186/s12906-017-1907-9
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Background: Extracts from perna canaliculus, the Green Lipped Mussel (GLM) are widely used as a complimentary therapy by patients with osteoarthritis (OA). The current study investigated the potential of a novel GLM formulation as a treatment for OA. A randomized double-blind placebo-controlled trial was undertaken to assess potential impacts on pain and quality of life following 12 weeks of treatment. Methods: Eighty patients with moderate to severe OA of the hip or knee were randomized to receive either 600 mg of BioLex (R)-GLM daily or placebo for 12 weeks. Entry criteria included a minimum 100 mm Visual Analogue Scale pain score (VAS) of 30 mm at baseline. The primary outcome was patient reported pain, measured by the Western Ontario and McMasters OA Index (WOMAC) pain subscale and VAS pain scale. Secondary outcomes included: quality of life (OAQol), total WOMAC score, WOMAC-20 responder criteria, and change in medication use over the study period. Participants were assessed at baseline, 12 weeks (end of therapy) and 15 weeks (3-weeks post-intervention). Results: At week 12, there were no significant differences in VAS or WOMAC pain subscale between active and placebo groups, nor significant improvement in the WOMAC-20 responder criteria or OAQol. Joint stiffness (measured by WOMAC-B stiffness) in the GLM group improved compared with placebo (p = 0.046). There was a significant difference in paracetamol use between the GLM treated group and the placebo group after week 12 (p = 0.001). Conclusions: BioLex (R)-GLM extract did not confer clinical benefit in moderate to severe OA over the intervention period, however, a significant difference in paracetamol use in the post-intervention period was observed between the BioLex (R)-GLM group and placebo group. Higher doses and/or longer treatment periods are worthy of future investigation.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] A randomized double-blind placebo-controlled trial to investigate the effectiveness and safety of a novel green-lipped mussel extract -BioLex® -for managing pain in moderate to severe osteoarthritis of the hip and knee
    Simon Stebbings
    Andrew Gray
    Anthony G. Schneiders
    Andrew Sansom
    BMC Complementary and Alternative Medicine, 17
  • [2] A NOVEL GREEN-LIPPED MUSSEL LIPID EXTRACT (BIOLEX) FOR THE TREATMENT OF PAIN IN OSTEOARTHRITIS OF THE HIP AND KNEE: A RANDOMIZED DOUBLE-BLIND, PLACEBO CONTROLLED TRIAL
    Stebbings, S.
    Gray, A.
    Schneiders, A.
    Sansom, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 755 - 755
  • [3] The Safety and Efficacy of an Enzyme Combination in Managing Knee Osteoarthritis Pain in Adults: A Randomized, Double-Blind, Placebo-Controlled Trial
    Bolten, Wolfgang W.
    Glade, Michael J.
    Raum, Sonja
    Ritz, Barry W.
    ARTHRITIS, 2015,
  • [4] Effectiveness and safety of steamed ginger extract on mild osteoarthritis: a randomized, double-blind, placebo-controlled clinical trial
    Baek, Hyang-Im
    Shen, Lei
    Ha, Ki-Chan
    Park, Yu Kyung
    Kim, Cha Soon
    Kwon, Jeong Eun
    Park, Soo Jung
    FOOD & FUNCTION, 2024, 15 (18) : 9512 - 9523
  • [5] A pilot, randomized, double-blind, placebo-controlled trial to assess the safety and efficacy of a novel Boswellia serrata extract in the management of osteoarthritis of the knee
    Majeed, Muhammed
    Majeed, Shaheen
    Narayanan, Narayanan K.
    Nagabhushanam, Kalyanam
    PHYTOTHERAPY RESEARCH, 2019, 33 (05) : 1457 - 1468
  • [6] Steroid injection for osteoarthritis of the hip - A randomized, double-blind, placebo-controlled trial
    Lambert, Robert G. W.
    Hutchings, Edna J.
    Grace, Michael G. A.
    Jhangri, Gian S.
    Conner-Spady, Barbara
    Maksymowych, Walter P.
    ARTHRITIS AND RHEUMATISM, 2007, 56 (07): : 2278 - 2287
  • [7] Curcuminoid Treatment for Knee Osteoarthritis: A Randomized Double-Blind Placebo-Controlled Trial
    Panahi, Yunes
    Rahimnia, Ali-Reza
    Sharafi, Mojtaba
    Alishiri, Gholamhossein
    Saburi, Amin
    Sahebkar, Amirhossein
    PHYTOTHERAPY RESEARCH, 2014, 28 (11) : 1625 - 1631
  • [8] Efficacy and safety of diacerein in osteoarthritis of the knee - A double-blind, placebo-controlled trial
    Pelletier, JP
    Yaron, M
    Haraoui, B
    Cohen, P
    Nahir, MA
    Choquette, D
    Wigler, I
    Rosner, IA
    Beaulieu, AD
    ARTHRITIS AND RHEUMATISM, 2000, 43 (10): : 2339 - 2348
  • [9] Randomized, double-blind, placebo-controlled glucosamine discontinuation trial in knee osteoarthritis
    Cibere, J
    Kopec, JA
    Thorne, A
    Singer, J
    Canvin, J
    Robinson, DB
    Pope, J
    Hong, P
    Grant, E
    Esdaile, JM
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2004, 51 (05): : 738 - 745
  • [10] Deer Bone Extract Supplementation for Mild-to-Moderate Knee Osteoarthritis Symptoms: A Randomized, Double-Blind, Placebo-Controlled Trial
    Shin, Dongseok
    Kim, Eun Ae
    Kim, Yoon Young
    Kim, Min Seo
    Kim, Jong Hoon
    Ahn, Chang Won
    Park, Soo-Hyun
    Lee, Ki Won
    Kim, Jae Hwa
    Kim, Ji Yeon
    JOURNAL OF MEDICINAL FOOD, 2018, 21 (02) : 159 - 166